MedicalSentry

Health Research Company

Clindamycin

generic name is CLINDAMYCIN PHOSPHATE

Why is this drug subscribed ?

Clindamycin is used to treat certain types of bacterial infections, including infections of the lungs, skin, blood, female reproductive organs, and internal organs. Clindamycin is in a class of medications called lincomycin antibiotics. It works by slowing or stopping the growth of bacteria. Antibiotics such as clindamycin will not kill the viruses that cause colds, flu, and other infections.

Active Substance: CLINDAMYCIN PHOSPHATE

Clindamycin Available Drugs :

Clindamycin ndc# 55154-2390

by Cardinal Health

INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE with active strength of 150 mg/mL

started marketing at 09/06/2011 .

Clindamycin ndc# 25021-115

by Sagent Pharmaceuticals

INTRAMUSCULAR, INTRAVENOUS INJECTION, SOLUTION with active strength of 150 mg/mL

started marketing at 15/05/2012 .

Clindamycin ndc# 0409-4050

by Hospira, Inc.

INTRAMUSCULAR, INTRAVENOUS INJECTION, SOLUTION with active strength of 150 mg/mL

started marketing at 25/05/2011 .

Clindamycin ndc# 0409-4054

by Hospira, Inc.

INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE with active strength of 150 mg/mL

started marketing at 24/07/1987 .

Clindamycin ndc# 0409-4053

by Hospira, Inc.

INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE with active strength of 150 mg/mL

started marketing at 24/07/1987 .

Clindamycin ndc# 0409-4052

by Hospira, Inc.

INTRAMUSCULAR, INTRAVENOUS INJECTION, SOLUTION with active strength of 150 mg/mL

started marketing at 25/05/2011 .

Clindamycin ndc# 0409-4051

by Hospira, Inc.

INTRAMUSCULAR, INTRAVENOUS INJECTION, SOLUTION with active strength of 150 mg/mL

started marketing at 25/05/2011 .

Clindamycin ndc# 0409-4055

by Hospira, Inc.

INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE with active strength of 150 mg/mL

started marketing at 24/07/1987 .

Clindamycin ndc# 0409-4197

by Hospira, Inc.

INTRAMUSCULAR, INTRAVENOUS INJECTION, SOLUTION, CONCENTRATE with active strength of 150 mg/mL

started marketing at 29/09/1988 .

Clindamycin ndc# 63323-282

by APP Pharmaceuticals, LLC

INTRAVENOUS INJECTION, SOLUTION with active strength of 150 mg/mL

started marketing at 22/11/2009 .

Clindamycin ndc# 52584-006

by General Injectables & Vaccines, Inc

INTRAMUSCULAR, INTRAVENOUS INJECTION, SOLUTION with active strength of 150 mg/mL

started marketing at 03/01/2010 .

Clindamycin ndc# 55390-109

by Bedford Laboratories

INTRAVENOUS INJECTION with active strength of 150 mg/mL

started marketing at 04/04/2005 .

Clindamycin Search Trends:

News :

Social Buzz

comments powered by Disqus